Effect of Anastrozole on Sex Hormone Levels and MCF-7 Cell Inhibition in Postmenopausal Women with Breast Cancer
- VernacularTitle:阿那曲唑对绝经后乳腺癌患者性激素水平的影响及人乳腺癌细胞的抑制作用
- Author:
Lingjiao FENG
1
;
Danping WANG
;
Weifang WU
;
Haiqin CHEN
Author Information
1. 台州恩泽医疗中心(集团)浙江省台州医院药剂科 浙江临海317000
- Keywords:
Anastrozole;
Postmenopausal;
Breast cancer;
Sex hormone levels;
MCF-7 Cell inhibition;
Tamoxifen
- From:
China Pharmacist
2017;20(10):1809-1812
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of anastrozole on sex hormone levels and michigan cancer foundation-7 ( MCF-7 ) cell inhibition in postmenopausal women with breast cancer. Methods: Totally 80 women with breast cancer were selected. Among them, 40 cases of patients received the routine management and tamoxifen treatment were included into the control group, and another 40 cases of patients received the routine management and anastrozole treatment were included into the observation group. The changes of sex hormone levels, effects and adverse drug reactions of two groups were compared between basetine and three months after treat-ment, meanwhile, the incidence of MCF-7 cell inhibition between two groups. Results:After treatment, the levels of estradiol( ER) , progesterone(PR) and luteotropic hormone(LH) were lower than baselime, however, the level of testosterone was contrary(P <0. 05). Meanwhile, the level of ER, PR and LH in control group were lower than baselime however, the level of testosterone was cont-ray (P<0. 05). The incidence of MCF-7 cell inhibillion between two grugs at time 72 h were higher than the 48 h, the incedence of MCF-7 cell inhibition in observation group were significantly higher than control groups at time 48 h and 72 h (P<0. 05). The rate of total effective in control group(45. 0%) was lower than the observation group(70. 0%)(P>0. 05). There was no significant differente in the micidence of adverse reactions. Conclusion:Anastrozole used for postmenopausal women with breast cancer has significant effi-cacy, high safety and promising inhibitory effect on MCF-7 cell. It can effectively adjust sex hormone level, reduce occurrence and transfer risks of breast cancer.
